Nadeem Tabbara Daria Gaut Caspian Oliai Tara Lewis Sven de Vos
10.1016/j.lrr.2021.100260
Leuk Res Rep
2021 Jul 14;16:100260.
cd19 chimeric antigen receptor t-cell therapy diffuse large b-cell lymphoma tafasitamab
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/34354920/
Case Reports
PMC8322434
34354920
Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL
2021